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Abstract 
Background: Plants from garcinia genus have been used for centuries against several diseases.
Objective: This study aimed to investigate the mechanism of apoptosis induced by epigarcinol and isogarcinol iso-
lated from the root of Garcinia ovalifolia (Clusiaceae) on human promyelocytic leukemia (HL-60 cells).
Methods: Epigarcinol and isogarcinol were isolated from the root of G. ovalifolia by using column chromatography 
method. The antiproliferative property of these molecules and fractions were assessed with 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. The light fluorescence microscope was utilized to observe the 
morphological changes of HL-60 cells after 24 h treatment. Early apoptosis and cell cycle distribution were analyzed 
by using flow cytometry (FCM).
Results: The results showed that epigarcinol and isogarcinol inhibited the proliferation of HL-60 and PC-3 cells in a 
concentration-dependent manner with IC50 varying between 4 and 76 µg/mL depending on the cell line and the 
molecule. The apoptosis rate and the number of apoptotic cells significantly increased with the augmentation of 
the concentration of the molecules. The results of flow cytometry (FCM) indicated that epigarcinol and isogarcinol 
induced significant G2/S arrest of HL-60 cells, the disruption of mitochondrial membrane potential and reactive oxy-
gen species (ROS) generation.
Conclusion: These results indicated that epigarcinol and isogarcinol demonstrated in vitro antiproliferative proper-
ties and induce apoptosis of HL-60 cells which is related to the G2/S arrest, and it exerts its apoptotic effect through 
the loosing of mitochondrial membrane potential.
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Background
The global burden of cancer continues to increase largely 
because of the aging and growth of the world popula-
tion alongside an increasing adoption of cancer-causing 
behaviors in economically developing countries. Based 
on the GLOBOCAN 2012 estimations, about 14.1 million 
cancer cases and 8.2 million cancer deaths are recorded 
in 2012. More than half of all cancers (56.8 %) and can-
cer deaths (64.9  %) in 2012 occurred in less developed 
regions of the world, and these proportions will increase 
further by 2025 [1]. Given the fact that the incidence rate 
of cancer disease is continuously increasing in Africa, 
a number of effective prevention measures have been 
introduced in order to substantially reduce the incidence 
and the mortality. Of all the efforts that have been made, 
the search for new anticancer compounds in foods or 
plant medicines is a realistic and promising approach to 
the prevention and the treatment of cancer [2]. Natural 
products, including plants, microorganisms and marines, 
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have been considered as valuable sources for anticancer 
drug discovery [3].With the high speed advances in bio-
medical research, there has been a growing interest in 
screening natural products for their potential use in dis-
ease prevention and treatment. These natural substances 
are of interest, as they are potential sources of anticancer 
compounds with minimal debilitating toxicity and side 
effects [4]. Because of the different components, herbs 
and plants may have synergistic activities or buffering 
toxic effects, mixtures or extracts of herbs might have 
more therapeutic or preventive activity than alone [5, 
6]. Several chemopreventive properties have long been 
attributed to polyphenolic compounds present in the 
human diet. One remarkable compound in this list is res-
veratrol, which possesses a wide range of pharmacologi-
cal properties, including antiinflammatory, antioxidant, 
and antiplatelet effects and has been proposed as a can-
cer chemotherapeutic agent [7, 8].
Garcinia ovalifolia (G. ovalifolia) which belongs to Clu-
siaceae family is growing in lowland forests tropical of 
Africa, Asia, America and Australia [9]. G. ovalifolia is a 
tree of 10–15 m high, with yellow sticky latex, generally 
distributed in fringing forests and riverbanks in West and 
central Africa [10]. The genus Garcinia includes some 200 
species found in the tropics, especially Asia and Africa. 
Plants from Garcinia genus demonstrated several phar-
macological proprieties including anti-HIV [10, 11], anti-
oxidant, antibacterial [12], cytotoxic [11, 12], anticancer 
and antimalarial [13]. The literature review shows that 
G. ovalifolia contains several molecules among which, 
isoxanthochimol [12, 14], endodesmiadol, canophyllol, 
canophyllal [12, 15], gallic acid, garcinane [16], 3-meth-
ylcheffouxanthone, two new friedelane triterpene deriva-
tives ovalifolone A and B [12]. Epi-garcinol, iso-garcinol 
and manniflavanone isolated from our plant (G. ovali-
folia) have also been discovered in other plants extract 
such as Garcinia preussii [17] Hypericum lanceolatum 
[18] Moronobea coccinea [19] Symphonia globulifera [20] 
and Garcinia bancana [21]. Several biological properties 
of epi-garcinol, iso-garcinol and manniflavanone have 
been investigated which included antiplasmodial [20–
23], antibacterial [17, 18] and immunosuppressant effects 
[24].Several biological properties of these molecules 
have been investigated such as antibacterial, cytotoxic-
ity activity on Artemia salina [13] and anti-HIV [25]. 
However, G. ovalifolia has not been studied for its anti-
cancer effects. Therefore, we attempted to investigate the 
growth-inhibitory and apoptotic effects of G. ovalifolia 




The Stem bark of Garcinia ovalifolia (Clusiaceae), was 
collected in Makenene (Centre region of Cameroon) in 
December 2010 and identified by Victor NANA of the 
National Herbarium Cameroon and a sample specimen is 
deposited on the voucher no. 20854/SRFCam.
Extraction and isolation of compounds
Air-dried and powdered stem bark of G. ovalifolia 
(2.5  kg) were macerated in methanol (5  L) for 48  h at 
room temperature. The solution obtained was then fil-
tered through Whatman No. 1 filter paper. The filtrate 
solution was concentrated under vacuum into a paste to 
give a dark brown crude extract (150 g). The slurry was 
made of crude extract (100  g) by dissolving in MeOH, 
adsorbed on 120 g of silica gel (60–120 mesh) which was 
subjected to Vacuum Liquid Chromatography (VLC) col-
umn packed with 800 g of silica gel (120–200 mesh). Elu-
tion was carried out using using hexane/ethyl acetate and 
ethyl acetate/methanol gradients as eluents at a flow rate 
of 2 mL/min. Fractions (250 mL each) were collected as 
follows: pure hexane (fractions 1–5), hexane/ethyl ace-
tate 75/25 (fractions 6–12), hexane/ethyl acetate 50/50 
(fractions 13–25),ethyl acetate (fractions 26–33), acetate/
methanol 90/10 (fractions 116–125) and methanol (frac-
tions 126–132). These fractions were pooled on the basis 
of the thin layer chromatography analysis on seven sub-
fractions from A to G respectively.
Further chemical investigation of sub- fractions B, C 
and D was carried out using column chromatography, 
preparative tin layer chromatography and recrystalliza-
tion in different solvent yielded three compounds: 7-epi-
garcinol (250  mg); isogarcinol (25  mg) manniflavanone 
(40  mg) respectively. All these structures were obtained 
by the means of spectroscopic analysis including 1D and 
2D NMR and mass spectra.
Cell culture
Human promyelocytic leukemia (HL-60 cells) and pros-
tate cancer (PC-3 cells) were obtained from European 
Collection of Cells Culture (ECCC), Sigma–Aldrich, 
India. They were grown in RPMI-1640 medium contain-
ing 10  % Fetal bovine serum (FBS),penicillin (100  IU/
mL) and streptomycin (100  µg/mL medium).The cells 
suspension was kept in the incubator (Thermocom 
Electron Corporation, USA) at 37  °C, 5  % CO2; 98  % 
humidity. Cells were used for different assays during log-
arithmic growth phase while the untreated control cul-
tures received only the vehicle (DMSO < 0.1 %).
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Cells viability and treatments
The human promyelocytic leukemia (HL-60 cells) and 
prostate cancer (PC-3 cells) were seeded in 96 different 
well plates containing 15 × 103 and 6 × 103 cells/100 µL/
well, respectively. The cultured cells were then treated 
(triplicate wells per condition) by adding 100 µL of serial 
dilutions of the three molecules (7-epigarcinol, isogar-
cinol and manniflavanone) in DMSO to give a final con-
centration of 100, 30, 10 and 1 µg/mL. The HL-60 treated 
cells were incubated immediately while for PC-3 cells, the 
molecules were added after 24 h of incubation. In addi-
tion, the DMSO alone was added to another set of cells 
as the solvent control (DMSO  <  0.1  %). The cells were 
then incubated for another 48 h prior to the addition of 
20 µL of 2.5 mg/mL solution of 3-(4, 5-dimethylthiazol-
2-yl)-2, 5-diphenyltetrazolium bromide (MTT) into each 
well. The incubation was continued for 3  h before the 
media was removed. A mixture of DMSO (150 µL) was 
added to each well and mixed to ensure dissolving of the 
crystal formazan before the absorbance at 570  nm was 
measured. Three replications of each experiment were 
performed and fifty percent of inhibitory concentration 
(IC50) of each extract was calculated.
DNA content and cell cycle phase distribution
HL-60 cells (1 ×  106 cells/2  mL/well) were treated with 
molecules at 20, 50, 100 µg/mL for 24 h. They were har-
vested and washed with 1 mL of PBS, then centrifuged at 
400 g for 5 min at 4 °C. The pellet was suspended in 100 µL 
of PBS and 900 µL of hypertonic citrate buffer (PI-25 µg/
mL, RNAase- 40 µg/mL, sodium citrate-0.1 % and Triton-
100X-0.03 %) and incubated at 37 °C in dark for 20 min. 
Finally, cells were analyzed immediately on flow cytom-
eter FACS Calibur (Becton–Dickinson, USA). The data 
were collected in list mode on 10,000 events and illus-
trated in a histogram, where the number of cells (counts) 
is plotted against the relative fluorescence intensity of PI 
(FL-2; λem: 585 nm; red fluorescence). The resulting DNA 
distributions were analyzed by Modfit (Verity Software 
House Inc., Topsham, ME) for the proportions of cells in 
G0–G1, S- phase, and G2-M phases of the cell cycle [26].
Hoechst 33258 staining of cells for nuclear morphology
HL-60 cells (2 ×  106 cells/3 mL/well) were treated with 
isogarcinol and 7-epigarcinol at different concentrations 
of extract for 24  h. They were collected, centrifuged at 
400 g and washed once with PBS. A solution of Hoechst 
(Hoechst, 10  µg/mL; citric 10  mM; Na2HPO4 0.45  M; 
Tween-20 0.05 %) was added in each tube and kept in the 
dark at room temperature for 30  min. The mixture was 
washed with PBS and the pellet suspended in 100 µL of 
PBS/glycerol (1:1). The solution (10 µL) was poured into 
the slide and nuclear morphology alterations observed 
under fluorescence microscope (Olympus ×70, magnifi-
cation ×20) [26].
Mitochondrial membrane potential (MMP) assay
HL-60 cells (1  ×  106 cells/2  mL/well) were treated with 
isogarcinol and 7-epigarcinol at different concentrations for 
24 h. Thirty minutes before the end of the experiment, the 
cell culture was treated with Rhodamine-123 (200 nM) and 
kept in the dark for 30 mn. Cells were collected, centrifuged 
(400  g; 4  °C; 5  min), the pellet was washed with 1  mL of 
PBS and centrifuged as mentioned earlier. The fluorescence 
intensity of 10,000 events was analyzed in FL-1 channel on 
BD FACSCalibur (Becton–Dickinson, USA) flow cytome-
ter. The decrease in fluorescence intensity because of mem-
brane mitochondrial potential loss was analyzed in FL-1 
channel and the change of potential membrane (∆ψm) was 
assessed by comparing fluorescence.
Reactive oxygen species (ROS) assay
ROS production was monitored by flow cytometry using 
2′,7′-dichlorodihydrofluorescin diacetate (DCFH2-DA). 
This dye is a stable non polar compound that readily dif-
fuses into cells and is hydrolyzed by intracellular ester-
ase to yield 2′,7′-dichlorodihydrofluorescin (DCFH2), 
which is trapped within the cells. Hydrogen peroxide 
or low molecular weight peroxides produced by the 
cells oxidizes DCFH2 to a highly fluorescent compound 
2′,7′-dichlorofluorescein (DCF). Thus, the fluorescence 
intensity was proportional to the amount of hydro-
gen peroxide produced by the cells. Briefly, HL-60 cells 
(1 ×  106 cells/2  mL/well) were treated with isogarcinol 
and epigarcinol at different concentrations for 24  h. 
Thirty minutes before the end of the experiment, the 
cell culture was treated with DCFH2-DA (50  µM) and 
kept in the dark. Cells were then collected, centrifuged 
(200 g; 4 °C; 5 min) and the pellet was washed with 1 mL 
of PBS and centrifuged as mentioned earlier. The pellet 
was suspended in 500 µL of PBS and the fluorescence 
was assessed by comparing two fluorescence emission 
480 nm/530 nm using a flow-cytometer (BD-LSR).
Statistical analysis
The viability experiments were done in triplicates and 
each data point represents the average of at least 3 inde-
pendent experiments. For other assays, three independ-
ent experiments were made and one of them had been 
chosen as result to post in this study.
Results
Cytotoxic effect of G. ovalifolia fractions on HL‑60 and PC‑3 
cells
To investigate the effect of G. ovalifolia fractions and 
extract on HL-60 and PC-3 cell proliferation, cells were 
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treated with different concentrations for 48 h. The cyto-
toxic effect of these fractions and extract G. ovalifolia 
on HL-60 and PC-3 cells was evaluated by MTT assay. 
As shown in Fig.  1, the addition of isogarcinol and epi-
garcinol to the cultured cells significantly inhibited the 
proliferation of these cells in a concentration-dependent 
manner (Fig. 1a, b).
The fifty percent inhibitory concentration (IC50) after 
48 h were 7, 8 and 12 μg/mL for HL-60 cells respectively 
for epigarcinol; isogarcinol and unknow molecule while 
for PC-3 cells these value are 7, 4 and 76 μg/mL respec-
tively for epigarcinol; isogarcinol and manniflavanone 
(Table 1). These results indicated that epigarcinol; isoga-
rcinol isolated from G. ovalifolia effectively inhibited the 
proliferation of both HL-60 and PC-3 cells and the anti-
proliferative activity of HL-60 cells greater than that of 
PC-3 cells. These two molecules (epigarcinol and isogar-
cinol) were used to continue the study.
Morphology changes of HL‑60 cells
To further confirm that cell apoptosis was induced by 
isogarcinol and epigarcinol from G. ovalifolia in HL-60 
cells, a morphological examination was performed by 
Hoechst staining. As shown in Fig.  2, the nuclear Hoe-
chst staining of the control cells was slightly blue and 
homogeneous, while cells treated with the two molecules 
exhibited morphological features of apoptotic cells, such 
as condensed chromatin with bright nuclear Hoechst 
staining. Under fluorescence microscope, the treated cell 
displayed an increase of cell damage and the level damage 
become higher when the concentration of the molecules 
is raised. Taken together, the obtained results indicate the 
induction of apoptosis in HL-60 cells after 24 h treatment 
with isogarcinol and epigarcinol.
Effect of B and C fractions on intracellular reactive oxygen 
species in HL‑60 cells
The generation of intracellular ROS is always associated 
with MMP disruption and cell apoptosis. To investigate 
this association, we examined the levels of ROS in HL-60 
cells treated with epigarcinol and isogarcinol. ROS was 
monitored by the oxidation-sensitive fluorescent dye 
2′,7′-dichlorofluoresceindiacetate (DCFH2-DA). A slight 
increase in DCF fluorescence was detected in the treated 
cells with both epigarcinol and isogarcinol (Fig.  3). A 
slight increase of fluorescence 4–6 times higher than the 
control was found after treatment of cells with isoga-
rcinol (10  µg/mL; Fig.  3A) and epigarcinol (5  µg/mL; 
Fig. 3B). At the concentration of 20 μg/mL, both epigar-
cinol and isogarcinol showed no ROS production this 
can be explained by the fact that at higher concentration, 
these two molecules act as antioxidant which neutralized 
and fixed ROS produced by the cells (Fig. 3C).
Fig. 1 Inhibitory effects and cytotoxicity of G. ovalifolia extracts. PC-3 and HL-60 cells were treated with different concentrations of G. olivalifolia 
fractions and extract for 48 h in triplicate. Cell viability was determined by MTT assay and indicated in percentage of cell viability of tree independ-
ent assays
Table 1 Fifty percent inhibition of  molecules isolated 
from G. ovalifolia
Results are expressed as mean ± SD; n = 3; Epi:7-epigarcinol; Iso: Isogarcinol; 
Man: manniflavanone; G: molecule with structure need to be elucidated
Cell IC50 (µg/ml)
Epigarcinol Isogarcinol Manniflavanone Unknown
PC-3 7 ± 1.9 8 ± 2.6 >100 12 ± 3.4
HL-60 7 ± 1.3 4 ± 2.1 76 ± 2.3 >100
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Mitochondrial membrane potential (ΔΨm)
The depletion of ΔΨm is one of the earliest intracellular 
events that occur following the induction of apoptosis. 
To determine whether an early loss of ΔΨm occurred 
during treatment with epigarcinol and isogarcinol in HL-
60cells, we performed ΔΨm measurement using Rh-123 
staining. In the untreated control cells, almost all cells 
were functionally active with high Rh-123 fluorescence 
and the percentage of mitochondrial damage was still low 
(9.11 %) (Fig. 4). The percentage of mitochondrial poten-
tial loss increased from 13.86 to 97.55  % for B fraction 
and 12.55 to 98.27  % isogarcinol when their concentra-
tion raised between 5 and 20 μg/mL (Fig. 4B). At 20 μg/
mL, both epigarcinol and isogarcinol isolated from G. 
ovalifolia caused mitochondrial damage and hence the 
decrease of mitochondrial membrane potential up to 
98  % corresponding of 10 fold compare to the control 
(Fig. 4B). The loss of ΔΨm is largely due to the opening 
of mitochondrial permeability transition pores (PTP), 
which conduit the leakage of cytochrome c and pro-
apoptotic proteins from mitochondria to the cytosol.
Effect of fractions of G. ovalifolia on cell cycle distribution
Quantitative analysis of DNA content with flow cytom-
etry was conducted in order to determine whether the 
G. ovalifolia fractions was associated with the induction 
of cell cycle arrest and the distribution of cells in differ-
ent phases of the cell cycle after 24 h exposure. After 24 h 
treatment with isogarcinol and epigarcinol, the HL-60 
cells exhibited concentration dependent increase in hypo 
diploid sub-G1 DNA fraction (<2nDNA). The results 
revealed an increase in the sub-G1 apoptotic fraction in 
both molecules from 7.37 % (5 µg/mL) to (88.89 %) 20 µg/
mL (epigarcinol) and 18.8 to 93.11  % (isogarcinol) when 
compared to the control (3.62 %) (Fig. 5). The G1/Go and 
G2/M phases block in HL-60 cells decrease significantly as 
result of the treatment with G. ovalifolia fractions when 
compared to vehicle control (Fig. 5B). An increase in sub 
G1 fraction is usually associated with apoptosis as a result 
of DNA fragmentation [27]. Both molecules isogarcinol 
and epigarcinol isolated from G. ovalifolia showed an 
apoptosis at 10 µg/mL (49.23 and 81. 29 %, respectively for 
epigarcinol and isogarcinol compared to the control. In 
the experiment to measure the change in the cell cycle of 
HL-60 cells after epigarcinnol and isogarcinol (10 µg/mL), 
the G2/M population was found to be drastically shifted 
to the sub-G1 population, while the significant reduction 
in the Go/G1 (Fig.  5C). Moreover, in the flow cytometry 
study, a sub-G1 peak, which was considered as an indi-
cator of cell apoptosis, was clearly observed after the 
treatment with epigarcinol and isogarcinol at the concen-
tration higher than (5 µg/mL) (Fig. 5A, B). These results 
Fig. 2 Effect of epi-garcinol and isogarcinol on nuclear morphological changes of HL-60 cells. After 24 h of treatment follow by staining with 
Hoechst 33258, the cells are incubated for 30 min and observed under fluorescence microscope. Olympus, Tokyo, Japan; magnification ×200). (Ao): 
Control; (A1): Camptotecin (2 µM); B: Epigarcinol (B1: 5 µg/mL; B2: 10 µg/mL; B3: 20 µg/mL); C Isogarcinol (C1: 5 µg/mL; C2: 10 µg/mL; C3: 20 µg/mL)
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suggested that HL-60 cells treated with the two molecules 
underwent the typical apoptosis. All these indicated that 
epigarcinol and isogarcinol arrested HL-60 cells at the 
G2/M phase, and primarily stimulated the cells from the 
G2/M phase to the sub-G1 phase of apoptosis.
Discussion
Different types of cancer chemopreventive agents, 
including natural substances and pharmaceutical com-
pounds, have been investigated for efficacy and efficiency 
in vitro and in vivo. The induction of apoptosis is known 
to be an efficient strategy for cancer therapy. Recently, 
extracts and molecules prepared from a variety of plants 
were demonstrated to possess the ability in triggering 
the apoptotic pathway [28]. Our study investigated the 
in  vitro effects of epigarcinol and isogarcinol from G. 
ovalifolia extract on cell growth, morphology, cell cycle 
of HL-60 cancer cell line and the mechanism of apoptosis 
induced these two molecules.
As commonly known, naturally polyphenols such as 
garcinol and isogarcinol exhibited cytotoxic activity 
against HL-60 and PC-3 cells. The two molecules inhib-
ited the proliferation of these two cells in a dose-depend-
ent manner (Fig. 1) with the IC50 varying between 5 and 
12  μg/mL (Table  1). Several studies demonstrated the 
growth inhibition properties of garcinol on different cells 
cancer including breast, lung, kidney, hepatocellular car-
cinoma, pancreatic [29–31]. The antiproliferative effects 
of isogarcinol was shown on HCT116 and CCRF-CEM 
cell lines [32].
It is also well known that in apoptosis, the earliest rec-
ognized morphological changes are compaction and 
segregation of the nuclear chromatin, with the result of 
chromatin margination and condensation of the cyto-
plasm. Our study demonstrated that epigarcinol and isog-
arcinol induced apoptosis of HL-60 cells as evidenced of 
alteration of cell morphology, DNA fragmentation, mito-
chondrial depolarization. After treatment of HL-60 cells 
with epigarcinol and isogarcinol for 24 h, a representative 
population of apoptotic cells was also observed mainly 
at 10 and 20  µg/mL, suggesting a rapid mechanism of 
apoptose induction that is gradually overwhelmed by the 
Fig. 3 Variation of ROS production of HL60 cells after treatment and analyzed by BD-FACS Caliber flow-cytometer; values are expressed as 
means ± standard error (n = 3). Ctrl: Control; 5; 10; 20µg/mL. Values affected with different letters are significantly different (p < 0.05) from the 
control; A isopigarcinol; B epigarcinol; C distribution of ROS fluorescence of isogarcinol and epigarcinol
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activation of apoptotic pathways. In the present study, 
the treated cells displayed significant apoptosis-related 
morphological alterations, such as apoptotic body for-
mation and chromatin condensation. The effects of gar-
cinol in tumor cells have been studied; its mechanism 
of action is elucidated for several cancer cells lines [29, 
33]. The mechanistic cytotoxic activity of garcinol simi-
lar to isogarcinol which may include downregulation of 
MMP-9, IL-8, PGE-2, and VEGF, markers of angiogenesis 
and metastasis in pancreatic cancer cell lines, Panc 1 and 
BxPC3 and induction of ROS through death receptor, 
mitochondrial and modulating GADD153 [34, 35].
ROS are involved in several different cellular processes 
ranging from apoptosis and necrosis to cell proliferation 
and carcinogenesis [36, 37], and the mitochondrion is a 
very important site of ROS production. Mitochondria are 
a source of ROS during apoptosis and reduced mitochon-
drial membrane potential leads to increase generation of 
ROS and apoptosis [38] ROS can induce and maintain 
the collapse of Δψm, leading to cellular damage through 
the oxidation of lipids and proteins, resulting in apoptotic 
cell death [39]. Controversially, other studies estimated 
that both mitochondria and ROS production seem to 
be involved in necrotic cell death [37, 40]. Whether the 
treated cells undergo apoptosis or necrosis depend on the 
concentration of ROS and the time of exposure to ROS 
[41]. Our results showed that epigarcinol and isogarcinol 
inhibited growth of HL-60 cells and induced apopto-
sis and ROS generation not in a dose-dependent man-
ner. Because cell cycle and apoptosis are involved in the 
regulation of cell growth, they were detected with a flow 
cytometer 24 h after the treatment with epigarcinol and 
isogarcinol in our study. The results showed that after 
treated with the two molecules for 24 h, the cells arrested 
at Go/G1 and G2/M phases decreased respectively and 
the increase of sub-G1, suggesting that these molecules 
induce significant apoptosis.
Even though apoptosis involves both intrinsic and 
extrinsic pathways, tumors arise more frequently through 
the intrinsic pathway than the extrinsic pathway because 
Fig. 4 Cell cycle analysis of HL-60 cells after treatment with molecules and analyzed by BD-FACS Caliber flow-cytometer. Ctrl: Control; 5; 10; 20 µg/
mL. Values are expressed as means ± standard error (n = 3). Values affected with different letters are significantly different (p < 0.05) from the con-
trol; A isogarcinol; B epigarcinol; C distribution of fluorescence of isogarcinol and epigarcinol
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of its sensitivity [42]. The main intrinsic pathway is char-
acterized by mitochondrial dysfunction, with the release 
of cytochrome c. Since mitochondria have the ability to 
activate the cellular apoptotic program directly, they are 
considered the major cellular component in the intrinsic 
way of apoptosis [43]. The mitochondria play an impor-
tant role in the progression of apoptosis. In the study, 
the decrease of Δψm was enhanced by increasing con-
centration of epigarcinol and isogarcinol. These results 
suggest that the two molecules indeed induced apopto-
sis in HL-60 cells A decrease in Δψm disrupts the outer 
mitochondrial membrane and causes the opening of the 
permeability transition pore, followed by the lease of 
pro-apoptotic factors, and resulting in subsequent apop-
tosis [44–47]. Other studies demonstrated the inhibi-
tion of CBP/p300 acetyltransferase activity by garcinol 
and several multiple biological effects in cancer cells, 
including the activation of DNA damage signaling and 
the induction of chromatin regulators such as TIP60 and 
SUV420 [47].
Conclusion
The bioassay-guided approach to the processing of G. 
ovalifolia led to the isolation and purification of epi-
garcinol and isogarcinol. We demonstrated that epi-
garcinol and isogarcinol from G. ovalifolia can inhibit 
the proliferation of HL-60 cells and this inhibitory 
effect was related to G2/M phase arrest and apopto-
sis the mitochondrial pathway. The cytotoxic results 
obtained from our work represent new insight into the 
traditional use of G. ovalifolia as an anticancer plant. 
Epigarcinol and isogarcinol may thus warrant further 
in vivo studies so as to develop it as a successful natu-
ral compound that could be used for the treatment in 
leukemia after determine the entire mechanism of its 
cytotoxicity.
Fig. 5 Cell cycle analysis of isogarcinol on HL-60 cells. After 24 h, treated cells were incubated with RNAse (40 µg/mL), stained with propidium 
iodide (25 μg/mL), and analyzed by BD-FACS Caliber flow-cytometer; Values are expressed as means ± standard error (n = 3); Values affected with 
different letters are significantly different (p < 0.05) from the control; A isogarcinol; B epigarcinol, C cells distribution in different phases of isogar-
cinol; D cells distribution in different phases of Epigarcinol
Page 9 of 10Pieme et al. BMC Res Notes  (2015) 8:700 
Authors’ contributions
PCA design, perform the study and write the manuscript; AP and YE carried 
out the purification of molecule, AKS provided all the reagent and chemical. 
All authors read and approved the final manuscript.
Author details
1 Department of Physiological Sciences and Biochemistry, Faculty of Medicine 
and Biomedical Sciences, University of Yaoundé I, PO Box 1364, Yaoundé, 
Cameroon. 2 Cancer Pharmacology Division, Indian Institute of Integrative 
Medicine, 180001, Canal Road, Jammu, India. 3 Department of Chemistry, 
Faculty of Sciences, University of Yaoundé I, PO Box 812, Yaounde, Cameroon. 
Acknowledgements
The authors wish to thank the Federation of Indian Chambers of Commerce 
and Industry (FICCI), who provided scholarships to Dr. PIEME C.A. through CV 
Raman program to conduct this research in the Indian Institute of Integrative 
Medicine (CSIR).
Competing interests
The author(s) declared no potential conflicts of interest with respect to the 
research authorship and/or publication of this article.
Received: 18 July 2014   Accepted: 19 October 2015
References
 1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, 
Parkin DM, Forman D, Bray F. Cancer Incidence and Mortality Worldwide: 
IARC Cancer Base 2013 No. 11 [Internet]. Lyon, France: International 
Agency for Research on Cancer. Available from http://globocan.iarc.fr.
 2. Xia D, Fang-Shi Z, Min L, Si-Guo G. Induction of apoptosis in human 
hepatoma SMMC-7721 cells by solamargine from Solanum nigrum L. J 
Ethnopharmacol. 2012;139:599–600.
 3. Schwartsmann G, Ratain MJ, Cragg GM, Wong JE, Saijo N, Parkinson 
DR, Fujiwara Y, Pazdur R, Newman DJ, Dagher R, Di Leone L. Anticancer 
drug discovery and development throughout the world. J Clin Oncol. 
2002;20(18):47S–59S.
 4. Tan ML, Sulaiman SF, Najimuddin N, Samian MR. Tengku Muhammad TS: 
methanolic extract of Pereskia bleo (Kunth) DC. (Cactaceae) induces apopto-
sis in breast carcinoma, T47-D cell line. J Ethnopharmacol. 2005;96:287–94.
 5. Li XK, Motwani M, Tong W, Bornmann W, Schwartz GK. Huanglian a Chi-
nese herbal extract, inhibits cell growth by suppressing the expression of 
cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells. Mol 
Pharmacol. 2000;58:1287–93.
 6. Vickers A. Botanical medicines for the treatment of cancer: rationale, 
overview of current data, and methodological considerations for phase I 
and II trials. Cancer Invest. 2002;20:1069–79.
 7. Orallo F. Comparative studies of the antioxidant effects of cis- and tran-
sresveratrol. Current Med Chem. 2006;13(1):87–98.
 8. Nigro P, Bloise E, Turco MC, Skhirtladze A, Montoro P, Pizza C, Piacente S, 
Belisario MA. Antiproliferative and pro-apoptotic activity of novel phe-
nolic derivatives of resveratrol. Life Sci. 2007;81(11):873–83.
 9. Magadula JJ. Bioactive benzophenone from stem bark and fruit hull from 
Garcina Senseii Verdc. Int J Phytochem Pharmacol. 2012;2(1):16–20.
 10. Gustafson KR, Blunt JW, Munro MHG, Fuller RW, McKee TC, Cardellina IIJH, 
McMahon JB, Cragg GM, Boyd MR. The guttiferones, HIY-inhibitory Ben-
zophenones from Svmuhonia alobulifera, w livinastonei, Garcinia ovalifolia 
and Clusia rosea. Telrahedron. 1992;46:10093–102.
 11. Magadula JJ, Suleimani HO. Cytotoxic and anti-HIV activities of some 
Tanzanian Garcinia species. Tanz J Health Res. 2010;12(2):1–7.
 12. Lannang AM, Noudou BS, Sewald N. Ovalifolone A and B: new friedelane 
derivatives from Garcinia ovalifolia. Phytochem Lett. 2013;6:157–61.
 13. Magadula JJ. Bioactive mammea type coumarins and benzophenone 
from two Clusiaceae plants. J Pharmaceut Sci Innov. 2012;1(5):31–3.
 14. Louh NG, Meli LA, Mbazoa DC, Tangmouo JG, Komguem J, Castillo J, 
Mofo NF, Naz Q, Lontsi D, Iqbal MC, Sondengam BL. Polyanxanthone A, B 
and C, three xanthones from the wood trunk of Garcinia polyantha Oliv. 
Phytochem. 2008;69:1013–7.
 15. Ngouamegne ET, Fongang RS, Ngouela S, Boyom FF, Rohmer M, Tsamo E, 
Gut J, Rosenthal P. Endodesmiadiol, a friedelane triterpenoid, and other 
antiplasmodial compounds from Endodesmia calophylloides. J Chem 
Pharm Bul. 2008;56:374–7.
 16. Meli Lannang A, Louh NG, Lontsi D, Specht S, Sarite SR, Florke U, Hussain 
H, Hoerauf A, Krohn K. Antimalarial compounds from the root bark of 
Garcinia polyantha Oliv. J Antibiotic 2008;61:518–523.
 17. Biloa MB, Ndjoko IK, Hertlein AB, Lannang AM, Nkengfack EA, Wolfender 
JL, Hostettmann K, Bringmann G. Preussianone, a New Flavanone-Chr-
omone Biflavonoid from Garcinia preussii Engl. Molecules. 2012;17:6114–
25. doi:10.3390/molecules17056114.
 18. Tchakam PD, Lunga KP, Kowa KT, Lonfouo NAH, Wabo KH, Tapondjou AL, 
Tane P, Kuiate JR: Antimicrobial and antioxidant activities of the extracts 
and compounds from the leaves of Psorospermum aurantiacum Engl. and 
Hypericum lanceolatum Lam. BMC Compl Altern Med 2012;12(136):1–8.
 19. Kim JJ, Chung IM, Jung JC, Kim MY, Moon HI. In vivo antiplasmodial activ-
ity of 11(13) -dehydroivaxillin from Carpesium ceruum. J Enzym Inhib Med 
Chem. 2009;24:247–50.
 20. Marti G, Eparvier V, Moretti C, Prado S, Grellier P, Hue N, Thoison O, 
Delpech B, Guéritte F, Litaudon M. Antiplasmodial benzophenone 
derivatives from the root barks of Symphonia globulifera (Clusiaceae). 
Phytochem. 2010;71:964–74.
 21. Vatcharin R, Wanpen N, Yaowapa S, Souwalak P. An Antibacterial Biphenyl 
Derivative from Garcinia bancana MIQ. Chem Pharm Bull. 2005;53(3):342–3.
 22. Noungoue DT, Chaabi M, Ngouela S, Antheaume C, Boyom FF, Gut J, 
Rosenthal PJ, Lobstein A, Tsamo E. Antimalarial compounds from the 
stem bark of Vismia laurentii. Z Naturforsch (C). 2009;64:210–4.
 23. Bero J, Quetin-Leclercq J. Natural products published in 2009 from plants 
traditionally used to treat malaria. Planta Med. 2011;77:631–40.
 24. Cen J, Shi M, Yang Y, Fu Y, Zhou H, Wang M, Su Z, Qun W. Isogarcinol is a 
new immunosuppressant. PLoS ONE. 2013;8(6):e66503. doi:10.1371/jour-
nal.pone.0066503.
 25. Kirk RG, Blunt JW, Murray HGM, Fuller RW, McKee TC, Cardellina IIJH, 
McMahon JB, Cragg GM, Boyd MR. The guttiferones, HIY-inhibitory Ben-
zophenones from Svmuhonia alobulifera, w livinastonei, Garcinia ovalifolia 
and Clusia rosea. Tetrahedron. 1992;48(46):10093–102. doi:10.1016/
S0040-4020(01)89039-6.
 26. Bhushan S, Kakkar V, Pal HC, Guru SK, Kumar A, Mondhe DM, Sharma PR, 
Taneja SC, Kaur IP, Singh J, Saxena AK. Enhanced anticancer potential of 
encapsulated solid lipid nanoparticles of TPD: a novel triterpenediol from 
Boswellia serrata. Mol Pharmarcol. 2013;10:225–35.
 27. Standera A, Marais S, Stivaktas V, Vorster C, Albrecht C, Lottering ML, 
Joubert AM. In vitro effects of Sutherlandia frutescens water extracts on 
cell numbers, morphology, cell cycle progression and cell death in a 
tumorigenic and a non-tumorigenic epithelial breast cell line. J Ethnop-
harmacol. 2009;124:45–60.
 28. Shu-Jing W, Lean-Teik N, Ching-Hsein C, Doung-Liang L, Shyh-Shyan W, 
Chun-Ching L. Antihepatoma activity of Physalis angulata and P. peruvi-
ana extracts and their effects on apoptosis in human Hep G2 cells. Life 
Sci. 2004;74(16):2061–73.
 29. Prasad S, Ravindran J, Sung B, Pandey MK, Aggarwal BB. Garcinol potenti-
ates TRAIL-induced apoptosis through modulation of death receptors 
and antiapoptotic proteins. Mol Cancer Therap. 2010;9(4):856–68.
 30. Subhash P, Aamir A, Nikhil O. Fazlul HS. Emerging role of Garcinol, the 
antioxidant chalcone from Garcinia indica Choisy and its synthetic ana-
logs. J Hematol Oncol. 2009;2(38):1–13.
 31. Nadia S, Gupta SV: Potential Role of Garcinol as an Anticancer Agent. J 
Oncol 2012 ID 647206. doi:10.1155/2012/647206.
 32. Kuete V, Tchakam PD, Wiench B, Ngameni B, Wabo HK, Tala M, Moungang ML, 
Ngadjui BT, Murayama T, Efferth T. Cytotoxicity and modes of action of four 
naturally occuring benzophenones: 2,2′,5,6′ tetrahydroxybenzophenone, 
guttiferone E, isogarcinol and isoxanthochymol. Phytomed. 2013;20(6):528–36.
 33. Ahmad A, Sarkar SH, Bitar B, Ali S, Aboukameel A, Sethi S, Li Y, Bao B, Kong 
D, Banerjee S, Padhye SB, Sarkar FH. Garcinol Regulates EMT and Wnt 
Signaling Pathways In Vitro and In Vivo, Leading to Anticancer Activity 
against Breast Cancer Cells. Mol Cancer Therap. 2012;11(10):2193–201.
 34. Ohnish H, Asamoto M, Tujimura K, Hokaiwado N, Takahashi S, Ogawa K, 
Kuribayashi M, Ogiso T, Okuyama H, Shirai T. Inhibition of cell proliferation 
by nobiletin, a dietary phytochemical, associated with apoptosis and 
characteristic gene expression, but lack of effect on early rat hepatocar-
cinogenesis in vivo. Cancer Sci. 2004;95(12):936–42.
Page 10 of 10Pieme et al. BMC Res Notes  (2015) 8:700 
 35. Cheng AC, Tsai ML, Liu CM, Lee MF, Nagabhushanam K, Ho CT, Pan 
MH. Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B 
cells through induction of ROS-dependent apoptosis. Food Funct. 
2010;1(3):301–7.
 36. Matés JM, Segura JA, Alonso FJ, Márquez J. Intracellular redox status and 
oxidative stress: implications for cell proliferation, apoptosis, and carcino-
genesis. Arch Toxicol. 2008;82:273–99.
 37. Marinho-Filho JDB, Bezerrab DP, Araújo AJ, Montenegro RC, Pessoa C, 
Diniz JC, Viana FA, Pesso ODL, Silveira ER, De Moraes MO, Costa-Lotufo 
LV. Oxidative stress induction by (+)-cordiaquinone J triggers both 
mitochondria-dependent apoptosis and necrosis in leukemia cells. Chem 
Biol Interact. 2010;183(3):369–79.
 38. Pieme Constant Anatole, Santoh Kumar G, Ngamegni B., Ngogang J, 
Shashi B, Tetsuya M, Ajit Kumar S. Ethyl acetate fraction of Garcina epunc-
tata inducesapoptosis in human promyelocytic cells (HL-60) through the 
ROS generation and G0/G1 cell cycle arrest: A bioassay-guided approach. 
Environ Toxicol Pharmacol. 2013;865–874.
 39. Castello-Branco MVS, Tavares JF, Silva MS, Barbosa-Filho JM, Anazetti MC, 
Frungillo L, Haun M, Melo-Diniz MFF, Melo PS. Xylodiol from Xylopia langs-
dorfiana induces apoptosis in HL60 cells. Revista Brasileira de Farmacog-
nosia Braz J Pharmacog. 2011;21(6):1035–42.
 40. Hillard EA, Abreu FC, Ferreira CCM, Jaouen G, Goulart MOF, Amatore C. 
Electrochemical parameters and techniques in drug development, with 
an emphasis on quinone and related compounds. Chemical Comm 
2008;2612–2628.
 41. Bartosz G. Reactive oxygen species: destroyers or messengers? Bioch 
Pharmacol. 2009;77:1303–5.
 42. Mohan S, Abdelwahab SI, Kamalidehghan B, Syam S, May KS, Harmal 
NSM, Shafifiyaz N, Hadi AHA, Hashim NM, Rahmani M. Involvement of 
NF-kB and Bcl2/Bax signaling pathways in the apoptosis of MCF7 cells 
induced by axanthone compound Pyranocycloartobiloxanthone A. 
Phytomed. 2012;19:1007–15.
 43. Ismail AA, Ahmad BA, Mohd AS, Rasedee A, Suvitha S, Behnam K, 
Mohamed Y, Manal-Mohamed ET, Siddig IA, Hapipah MA, Syam M. Den-
tatin isolated from Clausena excavata induces apoptosis in MCF-7cells 
through the intrinsic pathway with involvement of NF-kB signaling and 
G0/G1 cell cycle arrest: a bioassay-guided approach. J Ethnopharmacol. 
2013;145:343–54.
 44. Zimmermann KC, Green DR. How cells die: apoptosis pathways. J Allergy 
Clin. Immunol. 2001;108:S99–103.
 45. Bouchier-Hayes L, Lartigue L, Newmeyer DD. Mitochondria: pharmaco- 
logical manipulation of cell death. J Clin Invest. 2005;115:2640–7.
 46. Hong-xia L, Pan W, Quanhong L, Xiaoxia C, Yuetao Z, Yaping X. Cell cycle 
arrest and cell apoptosis induced by Equisetum hyemale extract in murine 
leukemia L1210 cells. J Ethnopharmacol. 2012;144:322–7.
 47. Collins HM, Abdelghany MK, Messmer M, Baigong Y, Deeves SE, Kindle 
KB, Kempegowda M, Akhmed A, Winkler GS, Kundu TK, Heery DM. Differ-
ential effects of garcinol and curcumin on histone and p53 modifications 
in tumour cells. BMC Cancer 2013;13(37): doi:10.1186/1471-2407-13-37.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
